Conference Coverage
Conference Coverage
Get ready for certolizumab for psoriasis
KAUAI, HAWAII – Women of childbearing potential may prefer it.
Latest News
Make a PEST of your psoriasis patients
KAUAI, HAWAII – Every psoriasis patient should complete the Psoriasis Epidemiology Screening Tool (PEST) for psoriatic arthritis annually.
Conference Coverage
Meta-analysis: Lifestyle changes improve psoriasis
GENEVA – Obese patients can reduce psoriasis severity and boost quality of life with diet or exercise.
Conference Coverage
Ixekizumab beats ustekinumab for fingernail psoriasis, hands down
GENEVA – Clear nails in half of ixekizumab users by week 24.
Conference Coverage
Prior biologic exposure doesn’t diminish ixekizumab’s efficacy
GENEVA – Ixekizumab works “extraordinarily well” for psoriasis – even with prior exposure to other IL-17 inhibitors.
Conference Coverage
Guselkumab crushes skin disease in psoriatic arthritis patients
GENEVA – IL-23 inhibitor achieves consistent skin outcomes in psoriasis with and without arthritis.
Conference Coverage
Interleukin-23 inhibition for psoriasis shows ‘wow’ factor
Most patients with moderate to severe plaque psoriasis on either guselkumab or tildrakizumab have at least PASI 90 sustained response at 2 years...
Conference Coverage
Topical tapinarof heads for phase 3 in atopic dermatitis and psoriasis
GENEVA – The aryl hydrocarbon receptor agonist is first-in-class.
Conference Coverage
VIDEO: Consider depression in patients with psoriasis
LAS VEGAS – Younger patients with significant disease may be at greater risk of depression and self-harm.
Latest News
Ustekinumab may reduce risk of nonmelanoma skin cancer
GENEVA – Risk was also lower among psoriasis patients treated with a TNF-inhibitor, but the difference was not significant.